AnaptysBio stock whipsawed Wednesday despite promising results for its experimental rheumatoid arthritis treatment.

This article helps to dispel myths related to rheumatoid arthritis (RA) and raise awareness regarding it. From causes to ...

A team of scientists from the University of Colorado has made an important discovery that could change how we understand and ...

Indian scientists have created an innovative self-actuating drug delivery system for Rheumatoid Arthritis, providing precise ...

A new Swedish study has, for the first time, shown a link between rheumatoid arthritis (RA) and cognitive decline in dementia ...

AnaptysBio shares surged 37% in premarket trading Wednesday after a mid-stage trial evaluating a rheumatoid arthritis treatment achieved its primary endpoint. Shares were recently trading around $17.

SAN DIEGO - AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company currently trading near its 52-week low at $12.38, announced significant findings from their Phase 2b RENOIR trial for ...

Women face a lot of health issues after menopause. Now in this article, we have mentioned whether early menopause increases ...

Robert Love is a neuroscientist who often shares health advice with his followers online. He recently turned his attention to ...

Early menopause, defined as occurring before age 45, results in a significant drop in estrogen and progesterone, raising the ...

Rheumatoid arthritis (RA) is an autoimmune disorder characterized by inflammation and bone erosion. The exact mechanism of RA is still unknown, but various immune cytokines, signaling pathways and ...

Arthritis and bursitis are common joint pain causes, but differ in origin and treatment. Arthritis inflames joints due to ...